Amarantus Bioscience Holdings Inc Stock OTC Bulletin Board
Equities
AMBS
US02300U1060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 8.57M |
---|---|---|---|---|---|
Net income 2014 | -27M | Net income 2015 | -25M | EV / Sales 2014 | - |
Net cash position 2014 | 89K | Net Debt 2015 | 2.96M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 08-01-13 | |
Founder | 42 | 08-01-13 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Founder | 79 | 08-01-13 | |
Founder | 42 | 08-01-13 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- AMBS Stock
- AMBS Stock